Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Bioxyne Limited ( (AU:BXN) ) has shared an announcement.
Bioxyne Limited, via its subsidiary Breathe Life Sciences, has signed a manufacturing agreement with Canadian-based Aurora Cannabis, a leading global medical cannabis company. The deal will see Breathe Life Sciences produce GMP-certified medicinal cannabis oils and, in an expanded scope, cannabis vapes for distribution into Australia, the UK and Germany.
Initial deliveries of medicinal cannabis oils into the Australian market have already commenced, validating Bioxyne’s GMP expertise and positioning it as a trusted supplier to a top-tier global player. The agreement, structured as a 12‑month rolling term with automatic renewal and six months’ notice for termination, is expected to enhance Bioxyne’s international footprint and underscores its growing credibility in pharmaceutical-grade cannabis manufacturing.
Both companies are progressing discussions to broaden the product portfolio beyond oils and vapes for the Australian, UK and German markets. This planned expansion suggests increased manufacturing volumes and deeper market penetration for Bioxyne, reinforcing its evolution from a primarily domestic operator to a globally recognised brand within the medical cannabis supply chain.
The most recent analyst rating on (AU:BXN) stock is a Buy with a A$0.06 price target. To see the full list of analyst forecasts on Bioxyne Limited stock, see the AU:BXN Stock Forecast page.
More about Bioxyne Limited
Bioxyne Limited is an Australian pharmaceutical and medical cannabis manufacturer listed on the ASX, operating through its wholly owned subsidiary Breathe Life Sciences. The company focuses on GMP-certified, pharmaceutical-grade medicinal cannabis products, including precision-dosed oils and emerging vape formats, targeting highly regulated markets such as Australia, the United Kingdom and Germany.
Average Trading Volume: 3,451,563
Technical Sentiment Signal: Buy
Current Market Cap: A$129.4M
For detailed information about BXN stock, go to TipRanks’ Stock Analysis page.